chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 42.0
Sex: M
Vaccine: FLU4, PPV
Symptoms: Body temperature increased, Erythema, Local swelling, Skin reaction, Tenderness
Clinical narrative: Patient had temp of 101.5 degrees, left arm swollen 12cm in diameater, tender, pink, localized reaction.
Age: 0.5
Sex: F
Vaccine: PNC13
Symptoms: Blood culture positive, Pneumonia pneumococcal, Pyrexia, Streptococcus test positive, Upper respiratory tract infection
Clinical narrative: Healthy 10 month old has received 3 doses of Prevnar vaccine per routine schedule. Develped fever for 24 hours and URI symptoms for a couple of weeks. Blood culture positive for strep pneumonaie.
Age: 0.5
Sex: F
Vaccine: PNC13
Symptoms: Vaccination failure, White blood cell count increased
Clinical narrative: Healthy 10 month old has received 3 doses of Prevnar vaccine per routine schedule. Develped fever for 24 hours and URI symptoms for a couple of weeks. Blood culture positive for strep pneumonaie.
Age: 17.0
Sex: F
Vaccine: FLU3
Symptoms: Rash
Clinical narrative: Rash to face/head and neck. Parent denied any other Sx's parent advised to take her daughter to a urgent care walk-in clinic for further evaluation, or to her PCP. Mother agreed.
Age: 63.0
Sex: M
Vaccine: PPV
Symptoms: Diarrhoea, Inflammation, Injection site erythema, Injection site pain, Nausea
Clinical narrative: Pain and redness at the injection site, nausea, vomiting/diarrhea, fever, inflammation.
Age: 63.0
Sex: M
Vaccine: PPV
Symptoms: Pyrexia, Vomiting
Clinical narrative: Pain and redness at the injection site, nausea, vomiting/diarrhea, fever, inflammation.
Age: 1.26
Sex: F
Vaccine: MMR
Symptoms: Blood test, Chills, Convulsion, Erythema, Feeling hot
Clinical narrative: Spiked fever of 104, legs had red hot hives.. chills and shaking.. fever never broke even with Tylenol. Went to doctor and it was reaction from mmr or virus. Fever went to 106. Went to er and she had a huge seizure.. fever lasted a week.
Age: 1.26
Sex: F
Vaccine: MMR
Symptoms: Pyrexia, Tremor, Urticaria, Vaccination complication
Clinical narrative: Spiked fever of 104, legs had red hot hives.. chills and shaking.. fever never broke even with Tylenol. Went to doctor and it was reaction from mmr or virus. Fever went to 106. Went to er and she had a huge seizure.. fever lasted a week.
Age: 70.0
Sex: F
Vaccine: FLUX, TTOX
Symptoms: Aphonia, Nausea, Nuclear magnetic resonance imaging abnormal, Oropharyngeal pain, Pharyngeal erythema
Clinical narrative: Shot - next day sore throat, 2 days deep red back of throat, lg bumps, large cross on my tongue, throat really bad, wanted to throw-up, felt like finger pushing on thyroid area - got MRI - 7 mm nodule on thyroid. Voice gravely - loss of voice.
Age: 70.0
Sex: F
Vaccine: FLUX, TTOX
Symptoms: Rash, Sensation of foreign body, Thyroid neoplasm, Tongue eruption
Clinical narrative: Shot - next day sore throat, 2 days deep red back of throat, lg bumps, large cross on my tongue, throat really bad, wanted to throw-up, felt like finger pushing on thyroid area - got MRI - 7 mm nodule on thyroid. Voice gravely - loss of voice.
Age: 19.0
Sex: F
Vaccine: YF
Symptoms: Dizziness, Loss of consciousness, Presyncope
Clinical narrative: After injection given, pt c/o of feeling dizzy. She then passed out and had a vagal response. Her mother was on one side holding pt in chair. Nurse was on the other side. Pt woke up within 20 seconds. Pt given cold compress and water. Pt placed in padded chair and observed for 15 minutes. Pt left with mom.
Age: 15.0
Sex: F
Vaccine: HPV4
Symptoms: Hyperhidrosis, Immediate post-injection reaction, Injected limb mobility decreased, Injection site pain, Nausea
Clinical narrative: Difficulty administering vaccine secondary resistance. Student reported immediate pain in areas radiation about 1 our later presented back to clinic with c/o diaphoresis, nausea. Allowed to lie down - sx improved. 1/6/14 after Christmas break, returned static, still with pain to (L) deltoid - improving slowly but pain decreased ROM (L) shoulder per mom.
Age: 1.04
Sex: F
Vaccine: FLU3, HEPA, HIBV, PNC13
Symptoms: Abnormal behaviour, Chills, Depressed level of consciousness, Eye movement disorder, Glassy eyes
Clinical narrative: IZ given at 0900 Tylenol admin. 0930 Mom reports following. "She was fine all day. Around 1600-1630 she started acting sore and getting feverish. Around 1700 she started acting very snuggly, 1730 her eyes became glassy, darting back and forth and no one was home. She looked shocky and started violently having and throwing up. She then started twitching, became extremely shivery and her eyelids closed to half mast, her body became limp like she was going unconscious. I called the hospital and they rec. to bring her to the ER. Half way here she started talking again, around 10-15 min. OK today at 0930.
Age: 1.04
Sex: F
Vaccine: FLU3, HEPA, HIBV, PNC13
Symptoms: Muscle twitching, Pain, Pyrexia, Retching, Vomiting
Clinical narrative: IZ given at 0900 Tylenol admin. 0930 Mom reports following. "She was fine all day. Around 1600-1630 she started acting sore and getting feverish. Around 1700 she started acting very snuggly, 1730 her eyes became glassy, darting back and forth and no one was home. She looked shocky and started violently having and throwing up. She then started twitching, became extremely shivery and her eyelids closed to half mast, her body became limp like she was going unconscious. I called the hospital and they rec. to bring her to the ER. Half way here she started talking again, around 10-15 min. OK today at 0930.
Age: 18.0
Sex: F
Vaccine: HPV4
Symptoms: Dizziness, Photopsia, Visual impairment
Clinical narrative: This spontaneous report as received from a physician refers to a 18 year old female patient. On 06-JUN-2013, the patient was vaccinated with the first dose of GARDASIL (lot # H021346; exp. date: 01-OCT-2015) (dose not provided). On 08-AUG-2013, she received her second dose of GARDASIL (lot # H021346; exp. date: 01-OCT-2015) (dose not provided). There were no concomitant medications. On 31-DEC-2013, when the patient was in the physician's office preparing to receive her third dose of GARDASIL, she told the physician that after her second dose on 08-AUG-2013, she experienced dizziness. The patient reported that she was "seeing stars and her vision was getting darker" for about one to 2 hours after receiving the dose. There was not given any treatment for the events. The patient recovered the same day on 08-AUG-2013 and she had not residual effects. Additional information has been requested.
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster, Rash
Clinical narrative: This spontaneous report as received from a physician refers to a male patient of unknown age. Relevant medical history and concomitant medication were not provided. On 26-DEC-2013 the patient was vaccinated with ZOSTAVAX 19400 PFU at a pharmacy. Lot number, dose, route and frequency were not provided. The following morning, on 27-DEC-2013, the patient awakened with a shingles-like rash on his buttocks and hips. The patient was examined by the physician who stated that the rash appeared to be shingles. The physician prescribed an unspecified antiviral medication for the patient, who filled the prescription on 30-12-2013. The prescription packet was accepted by the physician, and he will contact the patient to see if the patient will come back to his practice for collecting the specimen. The outcome of shingles was reported as not recovered/not resolved. The reporter causality was unknown. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: This spontaneous report as received from a consumer who was also the patient. The patient's gender and age were unknown (no demographic details were provided). The patient's medical history was unknown. The patient reported receiving a vaccination with ZOSTAVAX, subcutaneous on Saturday (calculated as 21-DEC-2013). No co-suspected or concomitant medications were reported. Now, on 23-DEC-2013, the patient had a red spot at the injection site which was sore. The outcome of the adverse events and a causality assessment were not provided. The patient disconnected before personal information could be obtained. Additional information is not expected.
Age: 27.0
Sex: F
Vaccine: MMR
Symptoms: Anaphylactic reaction, Dyspnoea, Pharyngeal oedema, Swollen tongue
Clinical narrative: This spontaneous report as received from a currently 39 year old female respiratory therapist refers to herself. Concurrent conditions included shellfish and iodine allergy. There was no pertinent medical history. In 2001 or 2002, the patient was vaccinated with MMRII (lot #, dose and route not provided). There were no concomitant medications. In the year 2001 or 2002, the patient developed a mild anaphylactic reaction following administration of MMRII. The respiratory therapist developed difficulty breathing, swelling of the tongue and swelling of the throat following vaccination with MMRII (time frame unspecified). On an unspecified date, the patient was treated with BENADRYL. No laboratory tests were performed. The consumer reported that in 2001 or 2002, within a couple of hours she was recovered. The consumer reported that when she was a child, she had received MMRII (unspecified how many doses and dates). Additional information is not expected.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a certified medical assistant, refers to an unknown number of patients of unknown demographics. The patient's concurrent conditions and medical history were not reported. On an unknown date in 2013, an unspecified number of patients received improperly stored Vaccine For Children (VFC) doses of GARDASIL (dose, route, lot and expiration date were not reported), exposed to 20F and 30F on multiple occasions, from 22-SEP-2013 until 20-DEC-2013 for 122 days. No adverse effects were reported (the reporter stated that the vaccines administered were RECOMBIVAX HB and VAQTA but on a second all was reported that no doses of VAQTA where involved in this excursion. This is the one of two reports from the same source. Additional information has been requested.
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Headache, Injection site erythema, Injection site induration, Injection site pain, Injection site rash
Clinical narrative: Injection site rash, induration, erythema, pain. Redness started 2 days after injection, other symptoms started 4 days after injection along with headache.
Age: 18.0
Sex: M
Vaccine: FLU3, HPV4
Symptoms: Balance disorder, Dizziness, Vertigo
Clinical narrative: Pt received Gardasil #1 10/29/13. On the evenings/nights of 10/29 and 10/30 he reported to his doctor feeling as if the room were "spinning", "dizzy" woke at night to use bathroom and walked or fell into his door. Felt off balance-during days and subsequent to this felt fine. Question if he can safely continue vaccine series. Also received flu vaccine same day.
Sex: F
Vaccine: FLUX
Symptoms: Activities of daily living impaired, Chills, Choking, Cough, Decreased appetite
Clinical narrative: This case was reported by a consumer via GSK employee and described the occurrence of influenza in an adult female subject who was vaccinated with Influenza vaccine unspecified (manufacturer unspecified). A physician or other health care professional has not verified this report. On an unspecified date in October 2013 the subject received a dose of Influenza vaccine unspecified (unknown). On 29 December 2013, 2 months after vaccination with Influenza vaccine unspecified, the subject experienced influenza and vaccination failure. "I don't I have ever been this sick!". The subject went to the doctors on 02 January 2014 to get pain medications "cause I can't sleep with all the hurting and high fevers". The subject reported "probably choking and having chills on New Year's Eve (31 December 2013)". The subject reported her "throat is do does" (not specified). On 03 January 2014 the subject felt "a little better since the doctor gave me something to make me rest. I slept finally last night some. Still can't get out of chair or bed and thy oat dire and coughing bad". The doctor told the subject to eat. The subject stated she had "no fever for two days so that is good". At the time of reporting the high fevers resolved; influenza, sick, can't sleep well all night and pain were improved. The events of decreased ability to perform daily activities, cough and lack of appetite were unresolved; choking, chills and throat disorder were unspecified. This case was assessed as medically serious by GSK.
Sex: F
Vaccine: FLUX
Symptoms: Influenza, Insomnia, Malaise, Mobility decreased, Pain
Clinical narrative: This case was reported by a consumer via GSK employee and described the occurrence of influenza in an adult female subject who was vaccinated with Influenza vaccine unspecified (manufacturer unspecified). A physician or other health care professional has not verified this report. On an unspecified date in October 2013 the subject received a dose of Influenza vaccine unspecified (unknown). On 29 December 2013, 2 months after vaccination with Influenza vaccine unspecified, the subject experienced influenza and vaccination failure. "I don't I have ever been this sick!". The subject went to the doctors on 02 January 2014 to get pain medications "cause I can't sleep with all the hurting and high fevers". The subject reported "probably choking and having chills on New Year's Eve (31 December 2013)". The subject reported her "throat is do does" (not specified). On 03 January 2014 the subject felt "a little better since the doctor gave me something to make me rest. I slept finally last night some. Still can't get out of chair or bed and thy oat dire and coughing bad". The doctor told the subject to eat. The subject stated she had "no fever for two days so that is good". At the time of reporting the high fevers resolved; influenza, sick, can't sleep well all night and pain were improved. The events of decreased ability to perform daily activities, cough and lack of appetite were unresolved; choking, chills and throat disorder were unspecified. This case was assessed as medically serious by GSK.
Sex: F
Vaccine: FLUX
Symptoms: Pyrexia, Throat irritation, Vaccination failure
Clinical narrative: This case was reported by a consumer via GSK employee and described the occurrence of influenza in an adult female subject who was vaccinated with Influenza vaccine unspecified (manufacturer unspecified). A physician or other health care professional has not verified this report. On an unspecified date in October 2013 the subject received a dose of Influenza vaccine unspecified (unknown). On 29 December 2013, 2 months after vaccination with Influenza vaccine unspecified, the subject experienced influenza and vaccination failure. "I don't I have ever been this sick!". The subject went to the doctors on 02 January 2014 to get pain medications "cause I can't sleep with all the hurting and high fevers". The subject reported "probably choking and having chills on New Year's Eve (31 December 2013)". The subject reported her "throat is do does" (not specified). On 03 January 2014 the subject felt "a little better since the doctor gave me something to make me rest. I slept finally last night some. Still can't get out of chair or bed and thy oat dire and coughing bad". The doctor told the subject to eat. The subject stated she had "no fever for two days so that is good". At the time of reporting the high fevers resolved; influenza, sick, can't sleep well all night and pain were improved. The events of decreased ability to perform daily activities, cough and lack of appetite were unresolved; choking, chills and throat disorder were unspecified. This case was assessed as medically serious by GSK.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a Certified Medical Assistant refers to an unspecified number of patients of unknown age and gender. Pertinent medical history and drug reactions/ allergies were not reported. On an unknown date, the patients were vaccinated with ZOSTAVAX (Lot number, dose and route were not reported) that was stored in an unmonitored freezer and exposed to unknown temperatures for an unknown period of time. Vaccine was unsupported in the absence of temperature excursion details. No adverse symptoms reported. Approximately 15 doses of ZOSTAVAX were administered. This is one of several cases from the same reporter. Additional information has been expected.
Age: 0.55
Sex: F
Vaccine: DTAPHEPBIP, FLU3, HIBV, PNC13
Symptoms: Cerebral calcification, Convulsion, Endotracheal intubation, Nuclear magnetic resonance imaging brain abnormal
Clinical narrative: Pt seen 12/27/13 for well visit (6 months). Pt was well at that visit. Given the following vaccines - DTaP - Hep B - Polio (PEDIARIX), PREVNAR, Hib, and Influenza. That evening proceeded to have a prolonged seizure. Taken via ambulance to Hosp. Required intubation, sedation and general anesthesia to stop seizure. MRI brain showed calcifications in area of basal ganglia. On KEPPRA.
Age: 46.0
Sex: F
Vaccine: FLU3
Symptoms: Choking, Hyperhidrosis, Myalgia, Neck pain, Pain
Clinical narrative: Developed hives, sneezing - choking, sweating - Lt sided myalgias - neck pains - achy within 2 hours (on 12/21/13) following flu shot.
Age: 46.0
Sex: F
Vaccine: FLU3
Symptoms: Sneezing, Urticaria
Clinical narrative: Developed hives, sneezing - choking, sweating - Lt sided myalgias - neck pains - achy within 2 hours (on 12/21/13) following flu shot.
Sex: U
Vaccine: FLU3
Symptoms: Convulsion, Exposure during breast feeding
Clinical narrative: This case was reported by a physician and described the occurrence of seizure in a neonate subject of unspecified gender exposed to FLULAVAL trivalent or quadrivalent unspecified (GlaxoSmithKline) transmammary over an unknown period when the mother was being treated for prophylaxis. On an unspecified date the mother of the subject received a dose of FLULAVAL (transmammary, unknown) and the infant subject experienced vaccine exposure via breast milk. Within months of vaccination with FLULAVAL, the infant subject experienced seizure. Physician reported that a mother received FLULAVAL in the hospital after she delivered her baby. The mother is currently breastfeeding the infant subject who has developed seizures. At the time of the report no additional information was provided. This case was assessed as medically serious by GSK. At the time of reporting the outcome of the seizures was unspecified.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report was received from a Community Nursing Services and refers to a patient of unknown age. On an unknown date the patient was vaccinated with PROQUAD (Merck) lot # H021358, expiry date 29-MAY-2014. Dosing information and route of administration were not provided. The PROQUAD (Merck) vaccine had been stored improperly. Follow up information has been received from a Registered Nurse, who stated that the doses of PROQUAD (Merck) lot # H021358, expiration date on 29-MAY-2014 were exposed to unknown temperature for 5 hours during interoffice transport. All vaccines were unsupported and were possibly administered to patients. No adverse symptoms reported. Nurse was unable to provide further temperature excursion details or dates of administration. All patients were revaccinated. No symptoms were reported. This is one of the several reports from the same source. Additional information is not expected.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Information was received from a health professional regarding a patient, demographics unknown, who on an unspecified date, was vaccinated with VARIVAX (Merck) lot # J003221, expiration date 15-MAR-2015, that had been improperly stored. The outcome of the vaccination was not provided. This is a corrected report. On 23-SEP-2013 information had been received from the registered nurse, who stated that the doses of VARIVAX (Merck), Lot # J003221, expiration date on 15-MAR-2015 were exposed to unknown temperatures for 5 hours during interoffice transport. All vaccines were unsupported and were possibly administered to patients. No adverse symptoms reported. Nurse was unable to provide further temperature excursion details or dates of administration. All patients were revaccinated. No symptoms were reported. This is one of several reports received from the same source. Additional information is not expected.
Age: 38.0
Sex: M
Vaccine: TDAP
Symptoms: Dysgeusia, Saliva discolouration
Clinical narrative: Pt presented to clinic for Tdap vaccine after stepping on a nail the morning before. Pt received ADACEL 0.5 ml IM in (L) deltoid. Pt called clinic back after leaving and stated, "About 10 minutes after I left from my shot I had this metallic taste in my mouth and spit up a little saliva that was red. I rinsed my mouth out and it's been fine ever since." Referred pt to his primary MD. Will follow up with patient.
Sex: U
Vaccine: MMR
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a Certified Medical Assistant refers to an unspecified number of patients of unknown age and gender. Pertinent medical history and drug reactions/allergies were not reported. On an unknown date, the patients were vaccinated with M-M-R II (Lot number, dose and route were not reported) that was stored in an unmonitored freezer and exposed to unknown temperatures for an unknown period of time. Vaccine was unsupported in the absence of temperature excursion details. No adverse symptoms reported. Approximately 7 doses of M-M-R II were administered. This is one of several cases from the same reporter.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from an other health professional refers to a patient of unknown gender and age. Medical history was not provided. On an unknown date the patient was vaccinated with improperly stored PROQUAD (Merck) (lot number J004322 with expiration date 17-OCT-2014). This is a corrected report. On 30-OCT-2013, information has been received from the registered nurse, who stated that the doses of PROQUAD (Merck) Lot # J004322, expiration date on 17-OCT-2014 were exposed to unknown temperature for 5 hours during interoffice transport. All vaccines were unsupported and were possibly administered to patients. No adverse symptoms reported. Nurse was unable to provide further temperature excursion details or dates of administration. All patients were revaccinated. No symptoms were reported. This is one of several reports received from the same source. Additional information is not expected.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a Certified Medical Assistant refers to an unspecified number of patients of unknown age and gender. Pertinent medical history and drug reactions/ allergies were not reported. On an unknown date, the patients were vaccinated with VARIVAX (Merck) (Lot number, dose and route were not reported) that was stored in an unmonitored freezer and exposed to unknown temperatures for an unknown period of time. Vaccine was unsupported in the absence of temperature excursion details. No adverse symptoms reported. Approximately 9 doses of VARIVAX (Merck) were administered. This is one of several cases from the same reporter. Additional information has been expected.
Age: 0.85
Sex: M
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: This spontaneous report as received from a physician refers to a 19 month old male patient (at the time of the event) diagnosed with spherocytosis. On 26-JUL-2013 the patient was vaccinated with VARIVAX (Merck) (lot and expiration date were not provided). Co-suspect or concomitant therapies were not reported. On 30-NOV-2013, 128 days after onset of therapy the patient was diagnosed with shingles after receiving VARIVAX (Merck). The outcome of shingles was unknown. Additional information has been requested.
Age: 29.0
Sex: F
Vaccine: FLUX
Symptoms: Eye discharge, Eye swelling, Lip swelling, Swelling face
Clinical narrative: Eyes began to have a yellow/green discharge. On the morning of 01/07/2014, awoke with swollen eyes, cheeks, and lips with excessive eye discharge.
Age: 39.0
Sex: M
Vaccine: FLUX, TDAP
Symptoms: Arthralgia, Blepharospasm, Blood glucose normal, Blood test normal, Burning sensation
Clinical narrative: After one hour hands, arms, face, and thighs started to tingle and burn. Called doc and they said go to ER if other reactions occur.  Saturday, Sunday, Monday, and Tuesday sympotoms progressed and migrated. has gotten worsening overall symptoms: pins and needles, burning, in face, hands, fingers, arms, feet and toes. Pain in hands, legs, and feet. Twitching in eye.  Cold, numbness in toes, hand function seems off, itching in feet, shivers, vibrations throughout upper and lower body, shaking left and right hand, pain in arms, joints, and legs. Called doc on 01/07/2014 and instructed to go to ER.  Peripheral Neuropathy (ED) diagnosed.
Age: 39.0
Sex: M
Vaccine: FLUX, TDAP
Symptoms: Chills, Hypoaesthesia, Nasopharyngitis, Neuropathy peripheral, Pain in extremity
Clinical narrative: After one hour hands, arms, face, and thighs started to tingle and burn. Called doc and they said go to ER if other reactions occur.  Saturday, Sunday, Monday, and Tuesday sympotoms progressed and migrated. has gotten worsening overall symptoms: pins and needles, burning, in face, hands, fingers, arms, feet and toes. Pain in hands, legs, and feet. Twitching in eye.  Cold, numbness in toes, hand function seems off, itching in feet, shivers, vibrations throughout upper and lower body, shaking left and right hand, pain in arms, joints, and legs. Called doc on 01/07/2014 and instructed to go to ER.  Peripheral Neuropathy (ED) diagnosed.
Age: 39.0
Sex: M
Vaccine: FLUX, TDAP
Symptoms: Paraesthesia, Pruritus, Tremor, Vibratory sense increased
Clinical narrative: After one hour hands, arms, face, and thighs started to tingle and burn. Called doc and they said go to ER if other reactions occur.  Saturday, Sunday, Monday, and Tuesday sympotoms progressed and migrated. has gotten worsening overall symptoms: pins and needles, burning, in face, hands, fingers, arms, feet and toes. Pain in hands, legs, and feet. Twitching in eye.  Cold, numbness in toes, hand function seems off, itching in feet, shivers, vibrations throughout upper and lower body, shaking left and right hand, pain in arms, joints, and legs. Called doc on 01/07/2014 and instructed to go to ER.  Peripheral Neuropathy (ED) diagnosed.
Age: 0.73
Sex: M
Vaccine: DTAP
Symptoms: Crying, Dyspnoea, Eye discharge, Insomnia, Lethargy
Clinical narrative: Difficulty Breathing, Mucus, Eye Discharge, Lethargy, Excessive Crying, Fever, Difficulty Sleeping, all until until 7 AM and later. Treatment- warm steam, cold vaporizer, rocking.
Age: 0.73
Sex: M
Vaccine: DTAP
Symptoms: Pyrexia
Clinical narrative: Difficulty Breathing, Mucus, Eye Discharge, Lethargy, Excessive Crying, Fever, Difficulty Sleeping, all until until 7 AM and later. Treatment- warm steam, cold vaporizer, rocking.
Age: 65.0
Sex: F
Vaccine: FLU3
Symptoms: Asthenia, Barium swallow, Blood test, Computerised tomogram, Dysphonia
Clinical narrative: WOKE UP WITH HOARSENESS IN VOICE AND LABORED BREATHING WEAKNESS IN HANDS, ARMS, LEGS & FEET.
Age: 65.0
Sex: F
Vaccine: FLU3
Symptoms: Dyspnoea, Echocardiogram, Electromyogram, Muscular weakness, X-ray
Clinical narrative: WOKE UP WITH HOARSENESS IN VOICE AND LABORED BREATHING WEAKNESS IN HANDS, ARMS, LEGS & FEET.
Age: 70.0
Sex: M
Vaccine: VARZOS
Symptoms: Headache, Pyrexia
Clinical narrative: This spontaneous report as received from other, as part of a marketing research program, refers to a 70 year old male patient with hypertension and high cholesterol. On an unknown date the patient was vaccinated with ZOSTAVAX (administered once, route, lot number and expiration date not reported). The patient on high blood pressure and cholesterol medicine as concomitant therapies. On an unknown date 1 day after receiving ZOSTAVAX the patient had fever and headache. The outcome of headache and fever was reported as recovered/resolved with sequelae on an unknown date. The reporter considered headache and fever to be related to ZOSTAVAX. The reporter considered the events as not serious. Additional information is not expected.
Age: 49.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Chills, Fatigue, Headache, Increased viscosity of bronchial secretion, Influenza like illness
Clinical narrative: 2 days after the vaccination a mild sore throat tiredness was felt. As time went on other flu like symptoms appeared. Sneezing, headache, fever, chills, congestion yellow thick sputum by the tenth day!!!
Age: 49.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Oropharyngeal pain, Pyrexia, Respiratory tract congestion, Sneezing
Clinical narrative: 2 days after the vaccination a mild sore throat tiredness was felt. As time went on other flu like symptoms appeared. Sneezing, headache, fever, chills, congestion yellow thick sputum by the tenth day!!!
Age: 49.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Nasal congestion, Oropharyngeal pain, Pyrexia, Respiratory tract congestion, Sneezing
Clinical narrative: 2 days after the vaccination a mild sore throat tiredness was felt. As time went on other flu like symptoms appeared. Sneezing, headache, fever, chills, congestion yellow thick sputum by the tenth day!!!
Age: 49.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Sputum discoloured
Clinical narrative: 2 days after the vaccination a mild sore throat tiredness was felt. As time went on other flu like symptoms appeared. Sneezing, headache, fever, chills, congestion yellow thick sputum by the tenth day!!!
Age: 75.0
Sex: M
Vaccine: PPV
Symptoms: Cellulitis
Clinical narrative: Cellulitis.
Age: 17.0
Sex: M
Vaccine: FLUC3
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: Flucelvax flu vaccine approved for 18 and older and was administered to 17 year old.
Age: 13.0
Sex: M
Vaccine: FLUC3
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: Flucelvax approved for 18 and older and was administered to 13 year old.
Age: 19.0
Sex: F
Vaccine: FLU3
Symptoms: Dizziness, Feeling hot, Hyperhidrosis, Hypopnoea
Clinical narrative: Patient felt faint, hot, sweaty, shallow breathing and dizzy.  Patient has fainted in the past and has had symptoms before in similar situations.
Age: 32.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Swelling
Clinical narrative: Redness/swelling.
Age: 49.0
Sex: F
Vaccine: FLUX
Symptoms: Joint range of motion decreased, Muscle rupture, Musculoskeletal pain, Pain in extremity, Wrong technique in drug usage process
Clinical narrative: Shoulder & arm to the elbow extremely sore; felt like torn muscle, limited range of motion.
Age: 37.0
Sex: M
Vaccine: FLUX
Symptoms: Cerebrovascular accident, Dizziness, Hypoaesthesia oral
Clinical narrative: Stroke and then another stroke 12/03/12. had symptoms beginning day after flu shot, dizziness, numb tip of tongue.
Age: 31.0
Sex: F
Vaccine: FLU3
Symptoms: Dizziness, Headache, Pain in jaw, Pyrexia
Clinical narrative: Fever of 100.4, light headed, headache and sore upper and lower jaw.
Age: 58.0
Sex: F
Vaccine: FLU3
Symptoms: Arthralgia, Local swelling, Muscular weakness, Myalgia, Restless legs syndrome
Clinical narrative: Severe restless leg syndrome. Weak legs and arms. Pain in joints and muscles. Swelling lower extremity. L>R
Age: 58.0
Sex: F
Vaccine: FLU3
Symptoms: Swelling
Clinical narrative: Severe restless leg syndrome. Weak legs and arms. Pain in joints and muscles. Swelling lower extremity. L>R
Age: 11.0
Sex: F
Vaccine: HPV4
Symptoms: Arthralgia, Blood test, Bone scan, Chest pain, Cyanosis
Clinical narrative: Joint pain, chest pain, headaches, mouth sores, irritated eyes, evolved to passing out, fingers turning blue, having new symptoms regularly.
Age: 11.0
Sex: F
Vaccine: HPV4
Symptoms: Electrocardiogram, Electroencephalogram, Eye irritation, Headache, Loss of consciousness
Clinical narrative: Joint pain, chest pain, headaches, mouth sores, irritated eyes, evolved to passing out, fingers turning blue, having new symptoms regularly.
Age: 11.0
Sex: F
Vaccine: HPV4
Symptoms: Nuclear magnetic resonance imaging, Stomatitis
Clinical narrative: Joint pain, chest pain, headaches, mouth sores, irritated eyes, evolved to passing out, fingers turning blue, having new symptoms regularly.
Age: 0.18
Sex: M
Vaccine: DTAP, HEP
Symptoms: Vomiting projectile
Clinical narrative: Projectile vomiting for a week.
Age: 45.0
Sex: F
Vaccine: FLU3
Symptoms: Eye irritation, Fatigue, Headache, Injection site erythema, Injection site swelling
Clinical narrative: Fatigue same day.  Headache that evening.  Day 2 and 3, unrelenting headache, malaise, muscle aches, fatigue, sleepiness, irritated eyes, body itchiness without rash.  Red, raised mark at injection site, minor swelling injection site, extremely sore arm.
Age: 45.0
Sex: F
Vaccine: FLU3
Symptoms: Malaise, Myalgia, Pain in extremity, Pruritus generalised, Somnolence
Clinical narrative: Fatigue same day.  Headache that evening.  Day 2 and 3, unrelenting headache, malaise, muscle aches, fatigue, sleepiness, irritated eyes, body itchiness without rash.  Red, raised mark at injection site, minor swelling injection site, extremely sore arm.
Age: 55.0
Sex: F
Vaccine: FLU3
Symptoms: Irritability, Mood altered
Clinical narrative: Mood changes irritable.
Age: 64.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Injection site pain
Clinical narrative: Pt received both injections as listed below. Pt states started to feel soreness only when sleeping on sides at injection sites approx. 1 week later. Soreness continues until pt reported reaction to pharmacy on 12/10. RPh followed up with pt on 01/01/14 - he states lifting weights x past 1 week improved soreness but still sore. Pt states will continue exercise x 1-2 more weeks, if soreness persists will contact PCP to be evaluated. Also, (L) deltoid more painful than (R) deltoid. No visible or palpable changes/abnormalities at either site.
Age: 62.0
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster, Malaise, Pain, Rash
Clinical narrative: Pt received ZOSTAVAX Monday 12-30-13, started feeling malaise and "achy" Wed 1-1-14 and started noticing rash by Saturday 1-4-14 rash spread from lower back all the way around on left side only and down to groin. Went to walk in clinic Sunday 1-5-14 and was prescribed VALTREX 1 gram 1 tablet by mouth every 8 hours. Has not seen improvement as of today 1-8-14 will follow-up with Dr in a weeks time. Pt diagnose with shingles.
Age: 10.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Mobility decreased, Pain in extremity, Swelling
Clinical narrative: Redness, a little swelling, arm very sore cannot raise it. Pt went to MD and received antibiotics (Cephalexin)
Age: 40.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Injected limb mobility decreased, Injection site oedema, Pain in extremity, Pyrexia
Clinical narrative: Redness of left arm and swelling from shoulder to elbow. Edema in upper arm. Severe pain resulting in limited range of motion of (L) arm. Pt ran fever as high as 102.4 x 3 days.
Age: 0.51
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Cellulitis, Injected limb mobility decreased, Injection site induration, Injection site swelling, Ultrasound scan abnormal
Clinical narrative: 1/7/14 Approximately 5-8 hrs post-vaccine administration Mom noticed right thigh swollen, hard to touch and immobile by infant. Patient taken to hospital ER. Mid thigh measurement at ER 26cm RT. Left thigh reference 22 cm. Patient followed up 1/8/14 with PCP. RT meas. 29cm. Ultrasound ordered.
Age: 65.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Body temperature increased, Fatigue, Immediate post-injection reaction, Injection site pain, Movement disorder
Clinical narrative: Pt reports arm was hurting immediately after getting flu and pneumovax shot. States she ran 101 degree temperature that night. Also c/o body aches, nausea and fatigue. Pt reports she could not raise her arms and could barely move her legs, pt states she has a red rash on the arm she rec'd the shots in and it also hot. Pt reports taking aspirin with Dramamine for s/s. Pt reports much better but not completely.
Age: 65.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Nausea, Rash erythematous
Clinical narrative: Pt reports arm was hurting immediately after getting flu and pneumovax shot. States she ran 101 degree temperature that night. Also c/o body aches, nausea and fatigue. Pt reports she could not raise her arms and could barely move her legs, pt states she has a red rash on the arm she rec'd the shots in and it also hot. Pt reports taking aspirin with Dramamine for s/s. Pt reports much better but not completely.
Age: 71.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Injection site discolouration, Injection site swelling, Pyrexia
Clinical narrative: Red and feverish. Black and blue spot where needle went in. Swollen. None yet.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Information was received from a health professional regarding a patient (demographics unknown), who on an unknown date, was vaccinated with VARIVAX (Merck) lot #J003221, expiration date 15-MAR-2015, that had been improperly stored. The outcome of improperly stored vaccination is unknown. This is a corrected report. On 23-SEP-2013, information received from a registered nurse stating that VARIVAX (Merck) was exposed to unknown temperatures for 5 hours during interoffice transport. No adverse symptoms reported. The patient was revaccinated. This is one of several reports received from the same source: 1311USA000056, 1310USA014891, 1310USA014881, 1310USA014883, 1310USA014888, 1310USA015417, 1311USA000071, 1311USA000012, 1310USA014858, 1310USA014850, 1310USA014870, 1311USA000289, 1311USA000282, 1310USA014874, 1310USA014861, 1310USA014866, 1310USA014868, 1310USA015422, 1310USA015165, 1311USA000069, 1310USA015424, 1311USA000058, 1311USA000042, 1311USA000013, 1310USA015170, 1311USA000014, 1310USA015153, 1310USA015090, 1311USA000067, 1311USA000064, 1311USA000021, 1311USA000020, 1311USA000022, 1310USA015101, 1310USA014853, 1311USA000075, 1310USA014895, 1310USA015119, 1310USA015113, 1311USA000059, 1311USA004931, 1311USA000065, 1311USA000739, 1311USA000040, 1310USA015096, 1311USA000642, 1310USA014958, 1311USA000072, 1310USA015127, 1311USA000053, 1311USA000085, 1311USA000741, 1311USA000744, 1311USA000083, 1310USA015141, 1311USA000006, 1311USA000005, 1310USA014900, 1310USA015268, 1310USA015264, 1310USA014896, 1310USA014909, 1311USA000627, 1310USA015396, 1310USA015270, 1311USA000637, 1310USA014962, 1311USA000039, 1311USA000037, 1311USA000034, 1311USA000032, 1311USA000002, 1310USA014897 and 1309USA011086. Additional information is not expected.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a caller who said that GARDASIL (start date, dose, route and lot # not reported) had been administered to an unspecified patient/patients. No side effects were mentioned. This is one of several reports received from the same source. It was linked to MARRS# 1401USA002803. Additional information is not expected.
Sex: U
Vaccine: MMR
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On an unknown date the patient was vaccinated with M-M-R II, injection (route, dose, lot number and expiration date not provided). The reporter stated that an unspecified office called and asked for stability information for MMR II. The reporter stated that the MMR II exposed to 68 Fahrenheit degree for 15 hours and was administered to a patient. No adverse effects were reported. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On 14-JUL-2013 the patient was vaccinated with the first dose of GARDASIL, injection (route, dose, lot number and expiration date). On 03-JAN-2014 the patient was vaccinated with the second dose of GARDASIL, injection (route, dose, lot number and expiration date). No adverse effects was reported. The outcome of event was not reported. Additional information has been requested.
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: This spontaneous report as received from a male physician (patient) reporting on himself. In 2006, physician was vaccinated with ZOSTAVAX, injection. (Dose, route and lot not provided). Co-suspect or concomitant therapies were not reported. Six months after receiving ZOSTAVAX in 2006, physician experienced a mild case of shingles. Physician reported his wife had six recurrences of shingles, after receiving ZOSTAVAX. At the time of the report the outcome and the causality for the event were unknown. This is one of several cases received from the same source. Additional information has been requested.
Sex: F
Vaccine: FLU3
Symptoms: Rash generalised
Clinical narrative: Case number PHHY2014US000956, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 510417) website on 06 Jan 2014. This report refers to a 53-year-old female patient. Past medical history included seasonal environmental allergies, hyperlipidemia, osteopenia and thyroid nodules. Concomitant medications included SINGULAIR, NASONEX, PRILOSEC, CRESTOR and fish oil. She was vaccinated with FLUVIRIN (batch number: 6652111482) intramuscularly into the right arm on 17 Oct 2013. On the same day approximately 6 hours after vaccination, she developed a rash at posterior neck, hairline, arms, legs and torso. The rash slowly worsened overnight. Treatment for the event was rendered with KENALOG and ZYRTEC. The outcome of the event was reported as recovered as of 30 Oct 2013. The seriousness and causality of the events were not reported.
Sex: F
Vaccine: FLU3
Symptoms: Guillain-Barre syndrome
Clinical narrative: Case number PHHY2014US000977, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 510596) website on 06 Jan 2014. This report refers to a 63-year-old female patient. Past medical history and concomitant medications were not reported. She was vaccinated with FLUVIRIN (batch number: 13385P) intramuscularly on 01 Oct 2013. On an unknown date after vaccination she developed Guillain-Barre syndrome. The outcome of the event was reported as condition unchanged as of 23 Oct 2013. The seriousness and causality of the events were not reported.
Age: 68.0
Sex: F
Vaccine: FLU3
Symptoms: Autoimmune disorder, Contraindication to vaccination, Dyspnoea, Muscular weakness, Nausea
Clinical narrative: Case number PHEH2013US022732 is an initial spontaneous report from the pharmacist received on 28 Oct 2013 with a follow up information received from vaccine adverse event reporting system (VAERS reference number: 510734) web site on 06 Jan 2014. This report refers to a 68-year-old female patient. She was allergic to thimerosal. Her concomitant medications were not reported. She was vaccinated with FLUVIRIN (batch number: 1309401, expiry date: Apr 2014) at a dose of 0.5 ml intramuscularly in the left arm on 11 Oct 2013. On 12 Oct 2013, she experienced nausea, rash in large areas of the body, muscle weakness, trembling and shortness of breath. She went to emergency room twice for the events nausea, rash and muscle weakness. She received prednisone 50 mg daily for 5 days. It was reported that the primary care physician suspected that flu shot triggered an autoimmune response. The outcome of the events was reported as condition unchanged. The seriousness and causality of the events were not reported. Follow up information received from vaccine adverse event reporting system (VAERS reference number: 510734) web site on 06 Jan 2014: Reporter (VAERS was added as reporter), site of vaccination, events (trembling, contraindication to vaccination and autoimmune response) and outcome was updated.
Age: 68.0
Sex: F
Vaccine: FLU3
Symptoms: Rash, Tremor
Clinical narrative: Case number PHEH2013US022732 is an initial spontaneous report from the pharmacist received on 28 Oct 2013 with a follow up information received from vaccine adverse event reporting system (VAERS reference number: 510734) web site on 06 Jan 2014. This report refers to a 68-year-old female patient. She was allergic to thimerosal. Her concomitant medications were not reported. She was vaccinated with FLUVIRIN (batch number: 1309401, expiry date: Apr 2014) at a dose of 0.5 ml intramuscularly in the left arm on 11 Oct 2013. On 12 Oct 2013, she experienced nausea, rash in large areas of the body, muscle weakness, trembling and shortness of breath. She went to emergency room twice for the events nausea, rash and muscle weakness. She received prednisone 50 mg daily for 5 days. It was reported that the primary care physician suspected that flu shot triggered an autoimmune response. The outcome of the events was reported as condition unchanged. The seriousness and causality of the events were not reported. Follow up information received from vaccine adverse event reporting system (VAERS reference number: 510734) web site on 06 Jan 2014: Reporter (VAERS was added as reporter), site of vaccination, events (trembling, contraindication to vaccination and autoimmune response) and outcome was updated.
Age: 57.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Blister, Bronchiolitis, Erythema, Excoriation, Polymerase chain reaction
Clinical narrative: This spontaneous report as received from a physician refers to a 57 year old female patient who was developmentally disabled history of seizure disorder. Current conditions included diabetes, asthma and allergic to SYMMETREL and "cholerasol". The patient's medical history included positive paratoloid (PPD) with no active tuberculosis (TB). On 10-DEC-2013 the patient was vaccinated with a dose of ZOSTAVAX (lot#, expiration date, dose not reported, subcutaneously). Concomitant medication included "multiple medications" including steroid inhaler. On an unknown date in December 2013 the patient developed a local reaction just below the site of the injection. The reaction appeared to be a large inflamed lesion on her arm now spreading to the patient's face and torso, with the appearance of chicken pox. Initially the localized reaction was described as a lesion: circular, macular, erythematous and slightly indurated, enlarging over several day reaching a maximum diameter of 7-8 centimeters in diameter. The rash on her face and torso appeared on an unspecified date as macular lesions, with vesicular papules in the center. There was no fever. Initially physician prescribed KEFLEX for a day or two on an unspecified date for the localized reaction, as the physician that it may be cellulitis. As the rash continued to develop and become systemic, the physician prescribed SEPTRA on an unspecified date. No lab work completed. The patient sought medical attention. The outcome of the event was reported as not recovered. Additional information has been requested.